Disease Burden of Respiratory Syncytial Virus in Korean Children: A Nationwide Cohort Study
- 5 May 2025
- journal article
- research article
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 44 (8) , 742-747
Abstract
Background: Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infections in young children globally. This study aimed to characterize the epidemiology, clinical burden, and risk factors associated with RSV infection in South Korean children under 5 years of age. Methods: This nationwide, population-based retrospective cohort study utilized national health insurance claims data from 2007 to 2019. RSV cases were identified using relevant International Classification of Diseases, 10th Revision codes, and incidence, hospitalization, and outpatient visit rates were calculated. Logistic regression analysis identified risk factors for hospitalization. Results: A total of 185,823 RSV cases were identified, with an annual incidence of 286.0 to 822.9 per 100,000 children under 5. Hospitalization was required for 44.7% of cases. Infants under 6 months had the highest risk of hospitalization, longer hospital stays and higher medical costs. Logistic regression identified younger age, comorbidities and metropolitan residence as independent risk factors for hospitalization. Infants 6–11 months of age constituted the largest proportions of inpatient (48.2%) and outpatient (33.6%) cases, and highest number of intensive care unit admission. Conclusion: RSV infection places a substantial burden on young children in South Korea, particularly infants. High hospitalization rates underscore the need for targeted public health preventive interventions, enhanced surveillance and improved access to timely medical care, to mitigate RSV’s impact and improve child health outcomes.Keywords
Funding Information
- Sanofi and AstraZeneca (NA)
This publication has 20 references indexed in Scilit:
- Change in Age profile of Respiratory Syncytial Virus disease over the course of annual epidemics: a multi-national studyJournal of Infection, 2024
- Nirsevimab for Prevention of Hospitalizations Due to RSV in InfantsNew England Journal of Medicine, 2023
- The disease burden of respiratory syncytial virus in InfantsCurrent Opinion in Infectious Diseases, 2023
- Why has the epidemiology of RSV changed during the COVID-19 pandemic?eClinicalMedicine, 2023
- Incidence, hospitalization, and mortality in children aged 5 years and younger with respiratory syncytial virus‐related diseases: A systematic review and meta‐analysisInfluenza and Other Respiratory Viruses, 2023
- Economic burden and health-related quality-of-life among infants with respiratory syncytial virus infection: A multi-country prospective cohort study in EuropeVaccine, 2023
- The Impact of RSV-Associated Respiratory Disease on Children in AsiaJournal of Pediatric Infectious Diseases, 2018
- Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling studyThe Lancet, 2017
- Epidemiology of Acute Viral Respiratory Tract Infections in Korean ChildrenJournal of Infection, 2000
- Respiratory Syncytial Virus Bronchiolitis in Infancy Is an Important Risk Factor for Asthma and Allergy at Age 7American Journal of Respiratory and Critical Care Medicine, 2000